针对恐惧记忆:在普遍的恐惧框架中检查药物干扰
Marcelo Giachero1, Agostina Belén Sacson1, María Belén Vitullo1
1Instituto de Neurociencia Cognitiva y Traslacional (INCYT), CONICET, Fundación INECO, Universidad Favaloro, Buenos Aires, Argentina.
Neurobiology of learning and memory
|July 14, 2024
概括
这项研究表明,propranolol可以通过调整小鼠在回忆过程中恐惧线索的概括来修改恐惧记忆. 这为治疗与创伤记忆相关的疾病提供了新的策略.
科学领域:
- 神经科学是一个神经科学.
- 行为科学 行为科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 记忆再巩固提供了一个治疗窗口来削弱创伤性记忆.
- 像灭绝这样的当前疗法对高度压力的记忆不那么有效.
- 一般化恐惧 (GF) 影响了恐惧记忆对调制的易感性.
研究的目的:
- 调查一般化恐惧 (GF) 的程度是否会影响强大的恐惧记忆的药理学调制.
- 探索兰醇在回忆过程中基于上下文相似性的恐惧记忆重组方面的潜力.
主要方法:
- 通过强烈恐惧调节在小鼠中诱导强烈的恐惧记忆.
- 通过改变与厌恶事件的上下文相似性来确定GF的梯度.
- 在不同情境和评估的行为变化中,在记忆检索后给予普拉诺洛尔.
主要成果:
- 当在非常相似的背景下 (CA,CB) 给药时,propranolol在男性中调节了恐惧记忆,将行为从被动转变为积极.
- 在女性中,在不太相似的环境 (CC) 中观察到罗的作用.
- 药物促进了行为灵活性,而不是消除恐惧记忆,表明记忆重组.
结论:
- 在回忆过程中控制恐惧概括可以间接操纵强大的上下文恐惧记忆.
- 普罗普拉诺洛尔的作用包括重组恐惧记忆,增强行为灵活性.
- 这种方法可以为涉及创伤记忆的精神疾病提供更有效,更少压力的治疗方法.
相关概念视频
Behavior Therapy
46
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
46
Preparedness and Phobias
99
Human fear responses to certain stimuli, such as darkness, heights, deep water, and blood, can often arise despite the absence of direct negative experiences. This phenomenon is rooted in evolutionary psychology, which posits that humans have developed a predisposition to fear stimuli that historically posed significant survival threats. This predisposition, known as preparedness, suggests that early humans who developed a fear of potentially dangerous entities, such as venomous snakes and...
99
Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K
Generalized Anxiety Disorder
87
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
87
Panic Disorder
69
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
69
GPCR Desensitization
5.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.9K


